The University of Tokyo: Culture of undifferentiated human iPS cells: Succeeded in ultra-high density
Kyoto University: Transplanting iPS immune cells into cancer patients:
COVID-19: Research on prevention of virus infection with iPS: ACE2-expressing iPS cells
Kyoto University: Utilizing iPS cells for cancer immunotherapy: Proliferating killer T cells
Kyoto University: Reproduce intractable disease ALS with iPS cells: Therapeutic drug “Bosutinib”